NCT02557802View on ClinicalTrials.gov

T-cell Diversity Following Intranasal and Intramuscular Vaccines

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

Fluenz Tetra

Intranasal spray, 0.2 ml dose

BIOLOGICAL

Fluarix Tetra

Intramuscular injection, 0.5 ml dose

Trial Locations (1)

GU2 7XP

Surrey Clinical Research Centre, Guildford

All Listed Sponsors
lead

University of Surrey

OTHER

NCT02557802 - T-cell Diversity Following Intranasal and Intramuscular Vaccines | Biotech Hunter | Biotech Hunter